Literature DB >> 15332388

Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma.

E Barreiro1, J Gea, C Sanjuás, R Marcos, J Broquetas, J Milic-Emili.   

Abstract

Blunted perception of dyspnoea under resistive loading has been observed in patients with a history of near-fatal asthma (NFA). The perception of dyspnoea at rest and at the end point of various exercises was assessed in such patients. Respiratory function and exercise capacity (6-min walking distance, incremental cycloergometry and inspiratory threshold loading) were assessed in seven NFA and eight non-NFA patients. Dyspnoea (Borg scale) was measured at rest and at the end point of the various exercises. Dyspnoea at rest was significantly lower in NFA patients. Although exercise tolerance was similarly reduced in both the NFA and non-NFA groups, dyspnoea at peak cycle exercise was significantly lower in the former (2.6+/-2 versus 6.1+/-3.8 (Borg scale; mean+/-SD)), who mainly (86%) stopped because of leg discomfort. A similar trend was observed in the 6-min walking distance and inspiratory threshold loading tests. Dyspnoea at peak exercise was the best indicator of the NFA condition, with a sensitivity of 100% and specificity of 63% for a Borg scale score of < or = 6. Perception of dyspnoea is blunted in near-fatal asthma patients at both rest and the end point of various forms of exercise. Dyspnoea at peak exercise is the best indicator of the near-fatal asthma condition.

Entities:  

Mesh:

Year:  2004        PMID: 15332388     DOI: 10.1183/09031936.04.00074703

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Assessment of dyspnea in asthma: validation of The Dyspnea-12.

Authors:  Janelle Yorke; Anne-Marie Russell; Jeff Swigris; Caroline Shuldham; Carol Haigh; Nikki Rochnia; Jennifer Hoyle; Paul W Jones
Journal:  J Asthma       Date:  2011-06-02       Impact factor: 2.515

2.  Habituation in neural processing and subjective perception of respiratory sensations.

Authors:  Andreas von Leupoldt; Andrea Vovk; Margaret M Bradley; Peter J Lang; Paul W Davenport
Journal:  Psychophysiology       Date:  2010-10-29       Impact factor: 4.016

3.  The impact of emotion on respiratory-related evoked potentials.

Authors:  Andreas Von Leupoldt; Andrea Vovk; Margaret M Bradley; Andreas Keil; Peter J Lang; Paul W Davenport
Journal:  Psychophysiology       Date:  2010-01-07       Impact factor: 4.016

4.  Impact of blunted perception of dyspnea on medical care use and expenditure, and mortality in elderly people.

Authors:  Satoru Ebihara; Kaijun Niu; Takae Ebihara; Shinichi Kuriyama; Atsushi Hozawa; Kaori Ohmori-Matsuda; Naoki Nakaya; Ryoichi Nagatomi; Hiroyuki Arai; Masahiro Kohzuki; Ichiro Tsuji
Journal:  Front Physiol       Date:  2012-07-04       Impact factor: 4.566

5.  Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects.

Authors:  Alida Benfante; Fabiano Di Marco; Silvia Terraneo; Stefano Centanni; Nicola Scichilone
Journal:  ERJ Open Res       Date:  2018-05-18

Review 6.  Pulmonary Rehabilitation and Asthma.

Authors:  Elisabetta Zampogna; Martina Zappa; Antonio Spanevello; Dina Visca
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

7.  Factors associated with discrepancies between poor dyspnea perception and abnormal lung function in 65 asthmatic patients.

Authors:  Asmaa Jniene; Leila Achachi; Mustapha El Bakkali; Laila Herrak; Aziza Rhanim; Souad Aboudrar; Taoufiq Dakka; Mustapha El Ftouh
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

8.  Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional study.

Authors:  Karen S Azevedo; Ronir R Luiz; Patricia Rm Rocco; Marcus B Conde
Journal:  BMC Pulm Med       Date:  2012-09-05       Impact factor: 3.317

9.  The EASI model: A first integrative computational approximation to the natural history of COPD.

Authors:  Alvar Agustí; Albert Compte; Rosa Faner; Judith Garcia-Aymerich; Guillaume Noell; Borja G Cosio; Robert Rodriguez-Roisin; Bartolomé Celli; Josep Maria Anto
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.